Satoshi Komoriya

623 citations

19 papers · 523 indexed · h-index 14

Co-authors: Takayasu Nagahara Noriyasu Haginoya Toshiharu Yoshino Tsuyoshi Hara Yukio Yokoyama Masahiro Iwamoto Hitoshi Yamaguchi Tsutomu Nagata
Topics: Blood Coagulation and Thrombosis Mechanisms (10 papers)Atrial Fibrillation Management and Outcomes (6 papers)Cancer therapeutics and mechanisms (4 papers)
Cited by: Hematology Organic Chemistry Genetics
Journals: Journal of Medicinal Chemistry British Journal of Pharmacology European Journal of Medicinal Chemistry
Partner nations: Japan Germany India

In The Last Decade

Satoshi Komoriya

19 papers receiving 505 citations

Peers

Countries citing papers authored by Satoshi Komoriya

Since Specialization

Citations

This map shows the geographic impact of Satoshi Komoriya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoshi Komoriya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoshi Komoriya more than expected).

Fields of papers citing papers by Satoshi Komoriya

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satoshi Komoriya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoshi Komoriya. The network helps show where Satoshi Komoriya may publish in the future.

Co-authorship network of co-authors of Satoshi Komoriya

This figure shows the co-authorship network connecting the top 25 collaborators of Satoshi Komoriya. A scholar is included among the top collaborators of Satoshi Komoriya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satoshi Komoriya. Satoshi Komoriya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Design, Synthesis, and Biological Evaluation of Novel 7-[(3aS,7aS)-3a-Aminohexahydropyrano[3,4-c]pyrrol-2(3H)-yl]-8-methoxyquinolines with Potent Antibacterial Activity against Respiratory Pathogens 2018 ·Journal of Medicinal Chemistry ·Takashi Odagiri,Hiroaki Inagaki,Masatoshi Nagamochi,Takahiro Kitamura,Satoshi Komoriya,Hisashi Takahashi	13
2	Discovery of Novel 7-[(1<i>R</i>,5<i>S</i>)-1-Amino-5-fluoro-3-azabicyclo[3.3.0]octan-3-yl]-6-fluoro-1-[(1<i>R</i>,2<i>S</i>)-2-fluorocyclopropane]-8-(methoxy or methyl)quinolones 2018 ·Chemical and Pharmaceutical Bulletin ·Satoshi Komoriya,Takashi Odagiri,Hiroaki Inagaki,Masatoshi Nagamochi,(unknown),(unknown),Takahiro Kitamura,Hisashi Takahashi	4
3	Design, Synthesis, and Biological Evaluation of Novel 8-Methoxyquinolones Bearing Fused Pyrrolidinyl Moieties at the C-7 Position with Potent Antibacterial Activity Against Respiratory Pathogens 2018 ·Heterocycles ·Takashi Odagiri,Hiroaki Inagaki,Takahiro Kitamura,Satoshi Komoriya,Hisashi Takahashi	5
4	Novel Nrf2 activators from microbial transformation products inhibit blood–retinal barrier permeability in rabbits 2014 ·British Journal of Pharmacology ·Yasuhiro Nakagami,(unknown),(unknown),Tatsuya Inoue,(unknown),(unknown),Yasunori Ono,Takashi Ohnuki,Yoko Murakami,Masaru Iwasaki,Kazuhiro Yoshida,(unknown),Satoshi Komoriya	21
5	Design, Synthesis, and Biological Evaluations of Novel 7-[7-Amino-7-methyl-5-azaspiro[2.4]heptan-5-yl]-8-methoxyquinolines with Potent Antibacterial Activity against Respiratory Pathogens 2013 ·Journal of Medicinal Chemistry ·Takashi Odagiri,Hiroaki Inagaki,Yuichi Sugimoto,Masatoshi Nagamochi,(unknown),(unknown),Takahiro Kitamura,Satoshi Komoriya,Hisashi Takahashi	29
6	Design, synthesis, and SAR of cis-1,2-diaminocyclohexane derivatives as potent factor Xa inhibitors. Part II: Exploration of 6–6 fused rings as alternative S1 moieties 2009 ·Bioorganic & Medicinal Chemistry ·Kenji Yoshikawa,Shozo Kobayashi,Yumi Nakamoto,Noriyasu Haginoya,Satoshi Komoriya,Toshiharu Yoshino,Tsutomu Nagata,(unknown),Kengo Watanabe,Makoto Suzuki,(unknown),(unknown)	34
7	Stereoselective synthesis and biological evaluation of 3,4-diaminocyclohexanecarboxylic acid derivatives as factor Xa inhibitors 2008 ·Bioorganic & Medicinal Chemistry Letters ·Tsutomu Nagata,Masatoshi Nagamochi,Shozo Kobayashi,Satoshi Komoriya,Toshiharu Yoshino,(unknown)	14
8	Discovery of N-[(1R,2S,5S)-2-{[(5-chloroindol-2-yl)carbonyl]amino}-5-(dimethylcarbamoyl)cyclohexyl]-5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamide hydrochloride: A novel, potent and orally active direct inhibitor of factor Xa 2008 ·Bioorganic & Medicinal Chemistry ·Tsutomu Nagata,Toshiharu Yoshino,Noriyasu Haginoya,Kenji Yoshikawa,Masatoshi Nagamochi,(unknown),Satoshi Komoriya,(unknown),(unknown),Mitsuhiro Yamaguchi,(unknown),Makoto Suzuki,(unknown)	33
9	Design, synthesis, and biological activity of novel factor Xa inhibitors: Improving metabolic stability by S1 and S4 ligand modification 2005 ·Bioorganic & Medicinal Chemistry ·Satoshi Komoriya,Shozo Kobayashi,(unknown),Toshiharu Yoshino,Tsutomu Nagata,Noriyasu Haginoya,Yumi Nakamoto,(unknown),Takayasu Nagahara,Makoto Suzuki,Takashi Shimada,Kengo Watanabe,(unknown),(unknown)	32
10	Design, synthesis, and biological activity of non-basic compounds as factor Xa inhibitors: SAR study of S1 and aryl binding sites 2005 ·Bioorganic & Medicinal Chemistry ·Satoshi Komoriya,Noriyasu Haginoya,Shozo Kobayashi,Tsutomu Nagata,(unknown),Masanori Suzuki,Toshiharu Yoshino,(unknown),Takayasu Nagahara,Makoto Suzuki,(unknown),(unknown)	22
11	Design, synthesis and biological activity of amidinobicyclic compounds (derivatives of DX-9065a) as factor Xa inhibitors: SAR study of S1 and aryl binding sites 2004 ·Bioorganic & Medicinal Chemistry ·Satoshi Komoriya,(unknown),Takayasu Nagahara,(unknown),(unknown),Yukio Yokoyama,(unknown),Tsuyoshi Hara	11
12	Design, synthesis, and biological activity of non-amidine factor Xa inhibitors containing pyridine N-oxide and 2-carbamoylthiazole units 2004 ·Bioorganic & Medicinal Chemistry ·Noriyasu Haginoya,(unknown),Satoshi Komoriya,Toshiharu Yoshino,Tsutomu Nagata,Yumiko Hirokawa,Takayasu Nagahara	27
13	Orally active factor Xa inhibitors: 4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine derivatives 2004 ·Bioorganic & Medicinal Chemistry Letters ·Noriyasu Haginoya,(unknown),Satoshi Komoriya,Yumiko Hirokawa,(unknown),Takayasu Nagahara	16
14	Synthesis and Conformational Analysis of a Non-Amidine Factor Xa Inhibitor That Incorporates 5-Methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine as S4 Binding Element 2004 ·Journal of Medicinal Chemistry ·Noriyasu Haginoya,(unknown),Satoshi Komoriya,Toshiharu Yoshino,Makoto Suzuki,Takashi Shimada,Kengo Watanabe,Yumiko Hirokawa,(unknown),Takayasu Nagahara	58
15	Facile Methods for Preparation of Thiazolopyridine and Tetrahydro-thiazolopyridine Derivatives 2004 ·Heterocycles ·Noriyasu Haginoya,Satoshi Komoriya,(unknown),Toshiharu Yoshino,Tsutomu Nagata,Masatoshi Nagamochi,(unknown),Mitsuhiro Yamaguchi,Takayasu Nagahara,(unknown)	17
16	ChemInform Abstract: Synthesis of Optically Active Aporphine and Morphinandienone Alkaloids via p‐Quinol Esters. 1996 ·ChemInform ·Hiroshi Hara,Satoshi Komoriya,(unknown),Osamu Hoshino	1
17	DESIGN, SYNTHESIS AND BIOLOGICAL ACTIVITIES OF ORALLY ACTIVE COAGULATION FACTOR Xa INHIBITORS 1995 ·European Journal of Medicinal Chemistry ·Takayasu Nagahara,(unknown),Yukio Yokoyama,(unknown),(unknown),Satoshi Komoriya,(unknown),Hitoshi Yamaguchi,Kiyoshi Tanabe,Y Morishima,Hiroaki Ishihara,Tsuyoshi Hara,Ken-ichi Yamazaki,Satoshi Kunitada,Masahiro Iwamoto	10
18	Synthesis of optically active aporphine and morphinandienone alkaloids via p-quinol esters 1995 ·Tetrahedron Asymmetry ·Hiroshi Hara,Satoshi Komoriya,(unknown),Osamu Hoshino	16
19	Dibasic (Amidinoaryl)propanoic Acid Derivatives as Novel Blood Coagulation Factor Xa Inhibitors 1994 ·Journal of Medicinal Chemistry ·Takayasu Nagahara,Yukio Yokoyama,(unknown),(unknown),Satoshi Komoriya,Hitoshi Yamaguchi,Tsuyoshi Hara,Masahiro Iwamoto	160

About Satoshi Komoriya

Satoshi Komoriya is a scholar working on Hematology, Genetics and Cardiology and Cardiovascular Medicine, having authored 19 papers that have together received 523 indexed citations. Recurring topics across this work include Blood Coagulation and Thrombosis Mechanisms (10 papers), Atrial Fibrillation Management and Outcomes (6 papers) and Cancer therapeutics and mechanisms (4 papers). The work is most often cited by research in Hematology (187 citations), Organic Chemistry (229 citations) and Genetics (69 citations). Satoshi Komoriya has collaborated with scholars based in Japan, Germany and India. Frequent co-authors include Takayasu Nagahara, Noriyasu Haginoya, Toshiharu Yoshino, Tsuyoshi Hara, Yukio Yokoyama, Masahiro Iwamoto, Hitoshi Yamaguchi, Tsutomu Nagata, Yumiko Hirokawa and Masatoshi Nagamochi. Their work appears in journals such as Journal of Medicinal Chemistry, British Journal of Pharmacology and European Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact